Landscape Capital Management L.L.C. Invests $2.04 Million in MetLife, Inc. $MET

Landscape Capital Management L.L.C. bought a new position in shares of MetLife, Inc. (NYSE:METFree Report) in the second quarter, HoldingsChannel reports. The firm bought 24,099 shares of the financial services provider’s stock, valued at approximately $2,039,000.

Other hedge funds also recently bought and sold shares of the company. Brighton Jones LLC raised its position in MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares during the last quarter. Caxton Associates LLP bought a new stake in shares of MetLife in the 1st quarter worth approximately $307,000. Empowered Funds LLC increased its stake in shares of MetLife by 187.6% during the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock valued at $2,680,000 after buying an additional 21,771 shares during the period. Sivia Capital Partners LLC purchased a new position in shares of MetLife during the second quarter valued at approximately $404,000. Finally, Jump Financial LLC bought a new position in shares of MetLife during the second quarter valued at approximately $444,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

  • Positive Sentiment: Wall Street Zen upgraded MetLife to a Buy rating, providing a favorable near-term sentiment catalyst for MetLife, Inc. (NYSE: MET). MetLife Upgraded by Wall Street Zen to Buy Rating
  • Positive Sentiment: Dowling & Partners issued a positive outlook for MetLife’s earnings, reinforcing expectations for continued operating strength. This view follows the company’s latest reported quarter, when earnings per share exceeded consensus estimates and revenue increased year over year. DOWLING & PARTN Issues Positive Outlook for MetLife Earnings
  • Neutral Sentiment: A review of life-insurance companies’ second-quarter results benchmarks MetLife (NYSE: MET) against its industry peers. The article may help investors assess relative performance, but the headline does not identify a new company-specific catalyst. Life Insurance Stocks Q2 Recap: Benchmarking MetLife
  • Neutral Sentiment: Multiple articles cover Bruno Mars’ concerts, schedules, weather, ticket availability and fan experience at MetLife Stadium. Although potentially relevant to the stadium’s venue business, MetLife, Inc. is an insurance and financial-services company; the stadium’s naming rights do not make these events a material direct driver of MET shares. Bruno Mars Opens Four Nights at MetLife Tonight

Analysts Set New Price Targets

MET has been the topic of several recent analyst reports. UBS Group lifted their price target on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Morgan Stanley upped their price objective on shares of MetLife from $93.00 to $103.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Wells Fargo & Company raised their target price on shares of MetLife from $101.00 to $109.00 and gave the stock an “overweight” rating in a research report on Wednesday. Mizuho lifted their target price on shares of MetLife from $95.00 to $102.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, Weiss Ratings upgraded shares of MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, June 15th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $101.64.

Read Our Latest Research Report on MET

MetLife Stock Up 1.0%

NYSE:MET opened at $94.44 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. The firm’s 50-day moving average price is $92.41 and its 200-day moving average price is $82.17. The company has a market capitalization of $60.77 billion, a PE ratio of 18.09, a P/E/G ratio of 0.73 and a beta of 0.78. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $100.93.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the company posted $2.02 EPS. MetLife’s revenue was up 10.5% on a year-over-year basis. On average, equities analysts predict that MetLife, Inc. will post 9.72 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be issued a dividend of $0.5925 per share. This represents a $2.37 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, August 4th. MetLife’s dividend payout ratio (DPR) is presently 45.40%.

MetLife declared that its Board of Directors has initiated a share buyback plan on Wednesday, August 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its shares are undervalued.

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Read More

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.